News
AVDL
16.30
+0.31%
0.05
Weekly Report: what happened at AVDL last week (0715-0719)?
Weekly Report · 3d ago
Weekly Report: what happened at AVDL last week (0708-0712)?
Weekly Report · 07/15 10:03
Oppenheimer’s top SMID ideas within high-growth themes
Oppenheimer’s top SMID ideas within high-growth themes. These stocks are high-conviction “SMID-cap” ideas for 2024 with a market cap of $1B to $10B. Oppenheimer research analysts outlined the top small-cap and mid-cap stocks that have exposure to several high- growth themes.
Seeking Alpha · 07/10 16:46
Weekly Report: what happened at AVDL last week (0701-0705)?
Weekly Report · 07/08 10:04
Avadel Pharmaceuticals Becomes Oversold (AVDL)
NASDAQ · 07/02 20:27
Weekly Report: what happened at AVDL last week (0624-0628)?
Weekly Report · 07/01 10:04
Avadel Pharmaceuticals Joins the Russell 3000® Index
TipRanks · 06/27 20:28
Avadel Pharmaceuticals To Join Russell 3000 Index, Effective At The Open Of Us Equity Markets On Monday, July 1, 2024
Avadel Pharmaceuticals plc is set to join the broad-market Russell 3000 Index in July 2024. The company is a biopharmaceutical company focused on transforming medicines to transform lives. The Russell 3000 will be effective at the open of US equity markets on July 1, 2024.
Benzinga · 06/27 20:07
Avadel Pharmaceuticals to Join Russell 3000® Index
Avadel Pharmaceuticals plc is set to join the broad-market Russell 3000 Index on July 1, 2024. The company is a biopharmaceutical company focused on transforming medicines to transform lives. Avadel will join the Russell 3000 at the conclusion of the 2024 Russell US Indexes annual reconstitution.
Barchart · 06/27 15:05
Weekly Report: what happened at AVDL last week (0617-0621)?
Weekly Report · 06/24 10:07
Jazz Pharmaceuticals: Pipeline Setback While Business Transition Continues
Seeking Alpha · 06/21 13:15
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
NASDAQ · 06/21 06:44
Oppenheimer Reaffirms Their Buy Rating on Avadel Pharmaceuticals (AVDL)
TipRanks · 06/17 11:45
Weekly Report: what happened at AVDL last week (0610-0614)?
Weekly Report · 06/17 10:03
Avadel Pharmaceuticals: Inflection Point Ahead
Seeking Alpha · 06/16 14:38
Weekly Report: what happened at AVDL last week (0603-0607)?
Weekly Report · 06/10 10:04
Weekly Report: what happened at AVDL last week (0527-0531)?
Weekly Report · 06/03 10:06
Weekly Report: what happened at AVDL last week (0520-0524)?
Weekly Report · 05/27 10:08
Avadel Pharmaceuticals Shares New LUMRYZ For Extended-Release Oral Suspension Data At SLEEP 2024 June 1-5, 2024
Avadel Pharmaceuticals plc will present 11 posters supporting the use of LUMRYZ as a narcolepsy treatment option at SLEEP 2024. Avadel will present at the 38th annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society in Houston.
Benzinga · 05/22 12:13
AVADEL PHARMACEUTICALS APPOINTS NASEEM AMIN, M.D. TO ITS BOARD OF DIRECTORS
Reuters · 05/21 11:00
More
Webull provides a variety of real-time AVDL stock news. You can receive the latest news about Avadel Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About AVDL
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's lead product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME and MEDUSA. Its MICROPUMP technology allows for the development of modified release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.